US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0117-5 D-0339-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0115-5 D-0338-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0113-5 D-0337-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0112-5 D-0336-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0110-5 D-0335-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0155-5 D-0334-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0140-5 D-0333-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0130-5 D-0332-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0105-5 D-0331-2023
Class II · Moderate risk Terminated

Verapamil Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.

Amerisource Health Services LLC D-0436-2023
Class III · Low risk Terminated

Clobetasol propionate Cream USP

Reason Subpotent Drug: Low assay result observed during long-term stability testing.

Lupin Pharmaceuticals Inc. NDC 68180-956-03 D-0174-2023
Class II · Moderate risk Terminated

Ohm Sanitizer Spray

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Urban Electric Power D-0264-2023
Class II · Moderate risk Terminated

Ohm Hand Sanitizer

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Urban Electric Power D-0263-2023
Class II · Moderate risk Terminated

Allopurinol Tablets 100mg

Reason Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Preferred Pharmaceuticals, Inc. D-0173-2023
Class II · Moderate risk Terminated

Diltiazem Hydrochloride Extended-Release Capsules

Reason Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

Sun Pharmaceutical Industries INC NDC 47335-679-81 D-0262-2023
Class III · Low risk Terminated

FentaNYL Citrate 2.5mg/50mL

Reason Short Fill: Underfilled units.

OurPharma LLC NDC 73013-1001-01 D-0172-2023
Class II · Moderate risk Terminated

Sterile Water for Injection

Reason CGMP Deviations: potential for trace amounts of product carryover.

Nephron Sc Inc NDC 0487-6105-01 D-0178-2023
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection

Reason CGMP Deviations: potential for trace amounts of product carryover.

Nephron Sc Inc D-0177-2023
Class II · Moderate risk Terminated

Allopurinol Tablets USP

Reason Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Accord Healthcare, Inc. NDC 16729-134-01 D-0168-2023
Class II · Moderate risk Terminated

Metoprolol Succinate Extended-Release Tablets

Reason Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.

Amerisource Health Services LLC NDC 68001-501-00 D-0269-2023
Class II · Moderate risk Terminated

Rocuronium Bromide Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC D-0099-2023